Back

Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring: qualitative findings from a randomized controlled trial in South Africa

Bardon, A. R.; Zondi, M.; Simoni, J. M.; Tlhaku, K.; Munatsi, P.; Bhengu, N.; Khanyile, M.; Gandhi, M.; Dorward, J.; Garrett, N.; Drain, P. K.

2025-03-11 hiv aids
10.1101/2025.03.07.25323040 medRxiv
Show abstract

Real-time, urine tenofovir testing may allow for clinic-based monitoring of adherence to antiretroviral therapy (ART). We aimed to assess (1) the acceptability of monthly point-of-care urine tenofovir testing over the first five months following ART initiation and (2) perspectives on the implementation of point-of-care urine tenofovir testing among people living with HIV (PLWH) and healthcare providers participating in a randomized controlled trial which used the urine test in South Africa. We conducted in-depth interviews with 20 PLWH six-months post-ART initiation and with eight healthcare providers. We assessed the acceptability (using constructs from the Theoretical Framework of Acceptability), appropriateness, feasibility, and willingness to use the point-of-care urine tenofovir test, as well as participants preferred form of adherence monitoring and perspectives on differentiated implementation strategies. Participants found monthly point-of-care tenofovir testing highly acceptable, preferrable to self-reported adherence measures, appropriate for this population, and potentially feasible to integrate with standard-of-care ART monitoring. Participants overall acceptability of routine urine tenofovir testing was shaped by experiences and perceptions that shaped their overall acceptability. Routine urine tenofovir testing was well-liked, perceived to be low-burden with few opportunity costs, and perceived to have several positive effects. These included encouraging consistent ART adherence, strong client-provider relationship and communications, and accurate self-reporting of adherence. Participants desire to impress and build trust with their provider motivated them to take their ART daily to achieve a positive adherence test result at each clinic visit. Overall, point-of-care urine tenofovir testing may be an acceptable and beneficial tool for motivating optimal adherence, improving ART adherence monitoring, and strengthening client-provider relations.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 4%
26.0%
2
Journal of the International AIDS Society
20 papers in training set
Top 0.1%
14.4%
3
AIDS and Behavior
14 papers in training set
Top 0.1%
10.1%
50% of probability mass above
4
PLOS Global Public Health
293 papers in training set
Top 1%
8.4%
5
BMJ Open
554 papers in training set
Top 4%
4.9%
6
JAIDS Journal of Acquired Immune Deficiency Syndromes
19 papers in training set
Top 0.2%
3.6%
7
BMC Public Health
147 papers in training set
Top 2%
3.6%
8
BMC Health Services Research
42 papers in training set
Top 0.8%
2.7%
9
Pilot and Feasibility Studies
12 papers in training set
Top 0.2%
1.9%
10
Journal of Medical Internet Research
85 papers in training set
Top 3%
1.7%
11
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.5%
12
JMIR Research Protocols
18 papers in training set
Top 1.0%
1.2%
13
BMC Infectious Diseases
118 papers in training set
Top 4%
1.2%
14
Tropical Medicine & International Health
15 papers in training set
Top 0.5%
1.0%
15
Open Forum Infectious Diseases
134 papers in training set
Top 2%
0.9%
16
AIDS
31 papers in training set
Top 0.4%
0.9%
17
BMJ Global Health
98 papers in training set
Top 2%
0.8%
18
Tropical Medicine and Infectious Disease
12 papers in training set
Top 0.4%
0.8%
19
Sexually Transmitted Infections
21 papers in training set
Top 0.4%
0.7%
20
International Journal of Environmental Research and Public Health
124 papers in training set
Top 7%
0.7%
21
Epidemics
104 papers in training set
Top 2%
0.6%
22
International Journal of Medical Informatics
25 papers in training set
Top 2%
0.6%
23
Peer Community Journal
254 papers in training set
Top 4%
0.6%
24
PLOS Medicine
98 papers in training set
Top 6%
0.5%
25
eLife
5422 papers in training set
Top 64%
0.5%
26
Frontiers in Microbiology
375 papers in training set
Top 11%
0.5%
27
Clinical Infectious Diseases
231 papers in training set
Top 6%
0.5%